359 results on '"Nitti, V."'
Search Results
2. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
3. Évaluation des performances cliniques et de la sécurité de l’InterStim™ micro-rechargeable chez les sujets atteints d’hyperactivité vésicale : résultats à 6 mois de l’étude Elite
4. OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials
5. Evaluation of rechargeable InterStim™ micro system performance and safety: 3-month results from the OAB cohort of the ELITE study
6. A0788 - Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study
7. Urétroplastie dorsale par greffon de muqueuse orale dans les sténoses de l’urètre féminin
8. Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder
9. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
10. Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial
11. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
12. Evaluation of the Female with Neurogenic Voiding Dysfunction
13. Impact de la radiothérapie sur les résultats fonctionnels du traitement chirurgical de l’incontinence d’effort chez l’homme et sur le rôle de l’urodynamique préopératoire
14. Does videourodynamic diagnosis of primary bladder neck obstruction in women predict success after bladder neck incision independent of detrusor pressure?
15. Sling revision for bladder outlet obstruction in women with primarily storage symptoms: What are the best urodynamic criteria to predict outcomes?
16. Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction?
17. Dorsal onlay buccal mucosa vs. vaginal-flap “Blandy” urethroplasty for female stricture: A single-center series
18. Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions
19. A0446 - Evaluation of rechargeable InterStim™ micro system performance and safety: 3-month results from the OAB cohort of the ELITE study
20. Neurostimulation tibiale postérieure percutanée pour hyperactivité vésicale chez la femme : une étude prospective monocentrique
21. Comparaison prospective non randomisée de la solifenacine et du mirabegron chez les patients atteints de sclérose en plaques ayant des symptômes d’hyperactivité vésicale
22. Faut-il placer une bandelette aponévrotique au moment de l’excision d’une bandelette sous-urétrale érodée ?
23. Prévalence et facteurs prédictifs de polyurie nocturne chez les patients ayant une nycturie
24. Révision de bandelette sous-urétrale pour hyperactivité vésicale de novo et suspicion d’obstruction : quel critère urodynamique d’obstruction sous-vésical prédit le mieux les résultats postopératoires
25. Aponévrose des grands droits ou du fascia lata pour la bandelette autologue pubo-vaginale : comparaison monocentrique des résultats périopératoires et fonctionnels
26. La chirurgie de désobstruction prostatique a-t-elle un role chez les patients atteints de maladie de Parkinson ?
27. Neuromodulation sacrée chez les patients atteints de maladie de Parkinson : une étude multicentrique
28. Photographie du traitement chirurgical de l’incontinence urinaire d’effort de la femme dans un centre tertiaire nord-américain
29. Évaluation échographique et traitement de la sténose urétrale de la femme par urétroplastie muqueuse buccale
30. Long-term efficacy: The Achille's heel of the male sling?
31. 431 - Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction?
32. 193 - Dorsal onlay buccal mucosa vs. vaginal-flap “Blandy” urethroplasty for female stricture: A single-center series
33. 141 - Sling revision for bladder outlet obstruction in women with primarily storage symptoms: What are the best urodynamic criteria to predict outcomes?
34. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse, and Fecal Incontinence
35. Association between age and low risk of clean intermittent catheterisation with onabotulinumtoxinA in overactive bladder patients with accompanying improvements in urinary symptoms and quality of life
36. Pathophysiology of Urinary Incontinence, Faecal Incontinence and Pelvic Organ Prolapse
37. Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study
38. 149 Durable duration of effect and positive treatment response with long-term onabotulinumtoxinA treatment in patients with over-active bladder syndrome: Final results of 3.5 years study
39. 567 - Association between age and low risk of clean intermittent catheterisation with onabotulinumtoxinA in overactive bladder patients with accompanying improvements in urinary symptoms and quality of life
40. LUTS: Etiology and Patient Assessment
41. Results and Tolerance of Prolonged Rifampicin Treatment in Recent and Chronic Forms of Pulmonary Tuberculosis
42. Experimental and Clinical Studies on the Antituberculous Activity of Rifampicin Alone or Combined with Other Drugs
43. Urethrolysis for Retention and Obstruction after Incontinence Surgery
44. Safety and tolerability of the β 3 ‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial
45. 577 Consistent improvements in urinary urgency following repeat onabotulinumtoxinA treatments in patients with overactive bladder syndrome and urinary incontinence
46. Réduction significative des épisodes d’incontinence urinaire et amélioration de la qualité de vie des patients traités par onabotulinum toxine A : analyse groupée de deux études contre placebo de phase 3
47. Content validity of the actionable bladder symptom screening tool (ABSST) in non-diabetic females with overactive bladder (OAB) and urgency urinary incontinence (UUI)
48. 401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials
49. 739 Cardiovascular (CV) assessments in short- and long-term Phase 3 mirabegron trials in patients with overactive bladder (OAB)
50. 744 OnabotulinumtoxinA 100U demonstrates similar treatment effect in overactive bladder patients with urinary incontinence regardless of number of prior anticholinergics taken or reason for their inadequate management of patients' overactive bladder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.